ÂÜÀòÂÒÂ×

Greg Mayes has held various leadership positions in multiple companies, including serving as President & CEO, Founder, and Board Member at Engage Therapeutics. Greg successfully led a Series A investment round and launched a late stage development company focused on an investigational product for seizures. Greg's experience also includes roles such as President and General Counsel at Unigene Laboratories, Inc. and Vice President, General Counsel, and Chief Compliance Officer at ImClone Systems. Greg has a background in law, with a J.D. magna cum laude from Temple University and a B.S. cum laude from Syracuse University.